Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19

BACKGROUND: The outbreak of coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 was first reported in Wuhan, December 2019, and continuously poses a serious threat to public health, highlighting the urgent need of identifying biomarkers for disease sever...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :J Allergy Clin Immunol
Главные авторы: Yang, Yang, Shen, Chenguang, Li, Jinxiu, Yuan, Jing, Wei, Jinli, Huang, Fengmin, Wang, Fuxiang, Li, Guobao, Li, Yanjie, Xing, Li, Peng, Ling, Yang, Minghui, Cao, Mengli, Zheng, Haixia, Wu, Weibo, Zou, Rongrong, Li, Delin, Xu, Zhixiang, Wang, Haiyan, Zhang, Mingxia, Zhang, Zheng, Gao, George F., Jiang, Chengyu, Liu, Lei, Liu, Yingxia
Формат: Artigo
Язык:Inglês
Опубликовано: American Academy of Allergy, Asthma & Immunology 2020
Предметы:
Covid-19
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7189843/
https://ncbi.nlm.nih.gov/pubmed/32360286
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaci.2020.04.027
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы